{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:35:46Z","timestamp":1791750946638,"version":"4.3.4"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To stratify adult-onset Still\u2019s disease (AOSD) patients in distinct clinical subsets to be differently managed, by using a multi-dimensional characterization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>AOSD patients were evaluated by using a hierarchical unsupervised cluster analysis comprising age, laboratory markers systemic score and outcomes. The squared Euclidean distances between each pair of patients were calculated and put into a distance matrix, which served as the input clustering algorithm. Derived clusters were descriptively analysed for any possible difference.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four AOSD patients clusters were identified. Disease onset in cluster 1 was characterized by fever (100%), skin rash (92%) and arthritis (83%), with the highest ferritin levels [mean (S.D.) 14\u00a0724\u2009\u2009(6837)\u2009ng\/ml]. In cluster 2, the onset was characterized by fever (100%), arthritis (100%) and liver involvement (90%), together with the highest CRP levels [288.10\u2009\u2009(46.01)\u2009mg\/l]. The patients in cluster 3 presented with fever (100%), myalgia (96%) and sore throat (92%). The highest systemic score values [8.88\u2009\u2009(1.70)] and the highest mortality rate (54.2%) defined cluster 3. Fever (100%) and arthritis (90%) were the symptoms at the onset in cluster 4, which was characterized by the lowest ferritin and CRP levels [1457\u2009\u2009(1298)\u2009ng\/ml and 54.98\u2009\u2009(48.67)\u2009mg\/l, respectively].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Four distinct phenotypic subgroups in AOSD could be suggested, possibly associated with different genetic background and pathogenic mechanisms. Our results could provide the basis for a precision medicine approach in AOSD in an attempt to find a clinical and laboratory multidimensional stratification and characterization, which would drive a tailored therapeutic approach in these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa904","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T15:22:49Z","timestamp":1607959369000},"page":"4844-4849","source":"Crossref","is-referenced-by-count":39,"title":["Dissecting the clinical heterogeneity of adult-onset Still\u2019s disease: results from a multi-dimensional characterization and stratification"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2808-1581","authenticated-orcid":false,"given":"Onorina","family":"Berardicurti","sequence":"first","affiliation":[{"name":"Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L\u2019Aquila, L\u2019Aquila"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Conforti","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L\u2019Aquila, L\u2019Aquila"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Iacono","sequence":"additional","affiliation":[{"name":"Rheumatology Section, Department of Precision Medicine, University of Campania \u2018Luigi Vanvitelli\u2019"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Pantano","sequence":"additional","affiliation":[{"name":"Rheumatology Section, Department of Precision Medicine, University of Campania \u2018Luigi Vanvitelli\u2019"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8928-2520","authenticated-orcid":false,"given":"Francesco","family":"Caso","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, School of Medicine, Rheumatology Unit, University of Naples Federico II, Naples"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Emmi","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Daniela","family":"Grembiale","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Catanzaro \u2018Magna Graecia\u2019, Catanzaro"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Cantatore","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgery Sciences, Rheumatology Unit, University of Foggia, Foggia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Atzeni","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Perosa","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Bari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Scarpa","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, School of Medicine, Rheumatology Unit, University of Naples Federico II, Naples"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2479-6958","authenticated-orcid":false,"given":"Giuliana","family":"Guggino","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology section, University of Palermo, Palermo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ciccia","sequence":"additional","affiliation":[{"name":"Rheumatology Section, Department of Precision Medicine, University of Campania \u2018Luigi Vanvitelli\u2019"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[{"name":"Department of Medicine, Unit of Allergology, Immunology, Rheumatology, University of Campus Bio-Medico of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cipriani","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L\u2019Aquila, L\u2019Aquila"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruscitti","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L\u2019Aquila, L\u2019Aquila"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"2021100217531516700_keaa904-B1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still\u2019s disease","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J Autoimmun"},{"key":"2021100217531516700_keaa904-B2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease","volume":"14","author":"Feist","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2021100217531516700_keaa904-B3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.1780300209","article-title":"Adult-onset Still\u2019s disease. clinical course and outcome","volume":"30","author":"Cush","year":"1987","journal-title":"Arthritis Rheum"},{"key":"2021100217531516700_keaa904-B4","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1080\/14712598.2019.1652591","article-title":"Biologics for the treatment of adult-onset Still\u2019s disease","volume":"19","author":"Yoo","year":"2019","journal-title":"Expert Opin Biol Ther"},{"key":"2021100217531516700_keaa904-B5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3899\/jrheum.170955","article-title":"Macrophage activation syndrome in patients affected by adult-onset Still disease: analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort","volume":"45","author":"Ruscitti","year":"2018","journal-title":"J Rheumatol"},{"key":"2021100217531516700_keaa904-B6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13075-020-02245-5","article-title":"Parenchymal lung disease in adult onset Still\u2019s disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients","volume":"22","author":"Ruscitti","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2021100217531516700_keaa904-B7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","article-title":"Adult onset Still\u2019s disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions","volume":"13","author":"Maria","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2021100217531516700_keaa904-B8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrrheum.2013.8","article-title":"The problem of choice: current biologic agents and future prospects in RA","volume":"9","author":"Choy","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"2021100217531516700_keaa904-B9","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/rheumatology\/kev421","article-title":"Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability","volume":"55","author":"Cuppen","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2021100217531516700_keaa904-B10","first-page":"83","article-title":"Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still\u2019s disease","volume":"37(Suppl 121","author":"Yang","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2021100217531516700_keaa904-B11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12916-016-0738-8","article-title":"Adult-onset Still\u2019s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers","volume":"14","author":"Ruscitti","year":"2016","journal-title":"BMC Med"},{"key":"2021100217531516700_keaa904-B12","doi-asserted-by":"crossref","first-page":"e0235326","DOI":"10.1371\/journal.pone.0235326","article-title":"Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still\u2019s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort","volume":"15","author":"Di Benedetto","year":"2020","journal-title":"PLoS One"},{"key":"2021100217531516700_keaa904-B13","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"2021100217531516700_keaa904-B14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","article-title":"Life-threatening complications of adult-onset Still\u2019s disease","volume":"33","author":"Efthimiou","year":"2014","journal-title":"Clin Rheumatol"},{"key":"2021100217531516700_keaa904-B15","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2021100217531516700_keaa904-B16","first-page":"2501","article-title":"Effect of different distance measures on the performance of K-means algorithm: an experimental study in Matlab","volume":"5","author":"Bora","year":"2014","journal-title":"Int J Comput Sci Inf Technol"},{"key":"2021100217531516700_keaa904-B17","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1109\/TPAMI.2002.1017616","article-title":"An efficient k-means clustering algorithm: analysis and implementation","volume":"24","author":"Kanungo","year":"2002","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"2021100217531516700_keaa904-B18","doi-asserted-by":"crossref","first-page":"012017","DOI":"10.1088\/1757-899X\/336\/1\/012017","article-title":"Integration K-means clustering method and elbow method for identification of the best customer profile cluster","volume":"336","author":"Syakur","year":"2017","journal-title":"IOP Conf Ser Mater Sci Eng"},{"key":"2021100217531516700_keaa904-B19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Ros\u00e1rio","year":"2013","journal-title":"BMC Med"},{"key":"2021100217531516700_keaa904-B20","doi-asserted-by":"crossref","first-page":"12232","DOI":"10.1038\/s41598-020-69031-w","article-title":"Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations","volume":"10","author":"Ruscitti","year":"2020","journal-title":"Sci Rep"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaa904\/35466698\/keaa904.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/10\/4844\/40500548\/keaa904.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/10\/4844\/40500548\/keaa904.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T14:03:00Z","timestamp":1633183380000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/10\/4844\/6065958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,1,6]]},"published-print":{"date-parts":[[2021,10,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa904","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,1,6]]}}}